EU health ministers to meet at 1600 GMT after EMA decision on AstraZeneca shot safety
Reuters
Published Apr 07, 2021 09:24AM ET
BRUSSELS (Reuters) -European Union health ministers will hold a meeting on Wednesday on vaccine rollouts after the EU drugs regulator announces its decision on the safety of the AstraZeneca (NASDAQ:AZN) COVID-19 vaccine, the EU presidency said.
Health Minister Marta Temido of Portugal, which holds the EU presidency, will host the gathering from 6 p.m. (1600 GMT) "following the public announcement of the conclusions of the Pharmacovigilance Risk Assessment Committee of EMA on the safety of the AstraZeneca vaccine," a spokeswoman for the Portuguese presidency wrote on Twitter.
EMA plans to announce its decision at 1400 GMT. Experts from the European drug authority have reviewed to what extent some cases of blood clotting in adults who had recently received the AstraZeneca vaccine may be linked to the injections.
"The meeting is aimed at harmonising the positions of the different EU member states, not only in order to halt the spread of disinformation, but also to reach a common understanding regarding vaccination efforts in the European Union," the Portuguese presidency said in a statement.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.